Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea
Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea
复制标题
DOI:
10.1093/sleep/25.1.59
复制
发表时间:
2002-02-01
期刊:
影响因子:
5.6
通讯作者:
Jones, KL
中科院分区:
文献类型:
--
作者:
Gozal, D;Lipton, AJ;Jones, KL
Study Objectives: Obstructive sleep apnea (OSA) is associated with intermittent hypoxia during sleep. Vascular endothelial growth factor (VEGF) has detectable levels in the circulation and its expression is highly regulated by oxygen tension. We therefore hypothesized that serum VEGF levels will be elevated in patients with OSA.Design: Blood samples were collected at random times during the day from fib adults and 41 children who were clinically suspected for the presence of OSA, and who underwent overnight polysomnography.Setting: University hospital sleep laboratory.Participants: N/AInterventions: N/AMeasurements and Results: For both children and adults, serum VEGF levels were significantly higher in polysomnographically confirmed OSA (AHI>15 and AI>5 in adults and children respectively) when compared to those with mild or no disease (p30 and an apnea index >5 were used as disease criteria in adults and children, respectively.Conclusions: We conclude that circulating VEGF levels are frequently elevated in OSA patients, and may play a role in the regulation of tissue oxygen delivery.